×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders.
21942426
2011
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
Budd-Chiari syndrome and heparin-induced thrombocytopenia in polycythemia vera: successful treatment with repeated TIPS and interferon alpha.
20160369
2010
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.
19287384
2009
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden.
19154659
2009
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.
19287382
2009
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
However, it is generally believed that JAK2 (V617F) is not the sole molecular abnormality in PV .
18717827
2008
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
17267906
2007
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia.
16484586
2006
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
Here, we describe a clonal and recurrent mutation in the JH2 pseudo-kinase domain of the Janus kinase 2 (JAK2 ) gene in most (> 80%) polycythaemia vera patients.
15793561
2005
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
A single point mutation (Val617Phe) was identified in JAK2 in 71 (97%) of 73 patients with polycythaemia vera , 29 (57%) of 51 with essential thrombocythaemia, and eight (50%) of 16 with idiopathic myelofibrosis.
15781101
2005
×
Entrez Id:
3717
Gene Symbol:
JAK2
JAK2
Polycythemia Vera
1.000
Biomarker
CTD_human
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
15858187
2005